Мобильная версия

Доступно журналов:

3 288

Доступно статей:

3 891 637

 

Скрыть метаданые

Автор Sandberg-Wollheim, M
Автор Ciusani, E
Автор Salmaggi, A
Автор Pociot, F
Дата выпуска 1995
dc.description We have analyzed the distribution of tumor necrosis factor (TNF) a and-b microsatellite alleles in HLA-DQ and-DR typed Swedish patients with multiple sclerosis (MS) (n=l22) and ethnically matched control subjects (n=l78). We found significant differences in the frequencies of TNFa and TNFb alleles between patients and controls. TNFal I was significantly associated with MS. This was also the case for the combination of TNFal I with TNFb4. However, TNFal I (alone or in combination with TNFb4) did not show any disease association independent of DQA 1*01021 DQBI*0602/DR2, whereas the previously reported strong association with HLA-DQAI*0102/DQBI*0602/DR2 in Scandinavian populations was confirmed. Therefore the association of TNFal I (and TNFb4) is most likely secondary to the increase of DQAI*0102/DQBl*0602/DR2 in MS patients. The proportion of TNFa6 positive individuals was lower among DR2-negative MS patients than among DR2-negative controls (p=0.08). Since the presence of the TNFab allele correlates with low TNFα production in response to lipopolysaccharide, it could be speculated that DR2-negative MS patients have an increased risk of being high TNFα producers in response to exogenous stimuli.
Издатель SAGE Publications
Тема TNFα
Тема microsatellites
Тема MS
Тема HLA
Тема genetics
Название An evaluation of tumor necrosis factor microsatellite alleles in genetic susceptibility to multiple sclerosis
Тип Journal Article
DOI 10.1177/135245859500100309
Electronic ISSN 1477-0970
Print ISSN 1352-4585
Журнал Multiple Sclerosis
Том 1
Первая страница 181
Последняя страница 185
Аффилиация Sandberg-Wollheim, M, Department of Neurology, Lund University Hospital, S-221 85 Lund, Sweden
Аффилиация Ciusani, E, Department of Neurology, Lund University Hospital, S-221 85 Lund, Sweden
Аффилиация Salmaggi, A, Istituto Nazionale Neurologico ‘C. BestaʼI-20 133 Milano, Italy
Аффилиация Pociot, F, Steno Diabetes Center, DK-2820 Gentof te, Denmark
Выпуск 3
Библиографическая ссылка 1 Martin R, McFarland HF, McFarlin DE. (1992) Immunological aspects of demyelinating diseases. Ann Rev Immunol 10: 153–187.
Библиографическая ссылка 2 Raine CS. (1991) Multiple sclerosis: a pivotal role for the T cell in lesion development. Neuropathol Appl Neubiol 17: 265–274.
Библиографическая ссылка 3 Selmaj K, Raine CS, Cannella B, Brosnan CF. (1991). Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87: 949–954.
Библиографическая ссылка 4 Tsukada N, Miyagi K, Matsuda M, Yanagisawa N. (1993). Increased levels of circulating intercellular adhesion molecule-1 in multiple sclerosis and human T-lympho-trophic virus type I-associated myelopathy. Ann Neurol 33: 646–649.
Библиографическая ссылка 5 Allen M et al. (1994) Association to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol 39: 41–48.
Библиографическая ссылка 6 Tienari P et al. (1994) Two-locus linkage analysis in multiple scleroses (MS). Genomics 19: 320–325.
Библиографическая ссылка 7 Nedwin GE et al. (1995) Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res 13: 6361–6373.
Библиографическая ссылка 8 Nedospasov SA et al. (1996) Tandem arrangement of genes coding for tumor necrosis factor (TNFα) and lymphotoxin (TNFβ) in the human genome. Cold Spring Harbor Symp Quant Biol 51: 611–624.
Библиографическая ссылка 9 Hof man FM, Hinton DR, Johnson K, Merrill JE. (1989). Tumor necrosis factor identified in multiple sclerosis. J Exp Med 170: 607–612.
Библиографическая ссылка 10 Beck J et al. (1988). Increased production of interferon γ and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand 78: 318–323.
Библиографическая ссылка 11 Merrill JE, Strom SR, Ellison GW, Meyers LW. (1989). In vitro study of mediators of inflammation in multiple sclerosis. J Clin Immunol 9: 84–96.
Библиографическая ссылка 12 Pociot F et al. (1991). A tumour necrosis factor beta gene polymorphism in relation to monokines secretion and insulin-dependent diabetes mellitus. Scand J Immunol 33: 37–49.
Библиографическая ссылка 13 Pociot F et al. (1993). Association of tumor necrosis factor (TNF) and class II MHC alleles with the secretion of TNFα and TNFβ by human mononuclear cells: A possible link to insulin-dependent diabetes mellitus. Eur J Immunol 23: 224–231.
Библиографическая ссылка 14 Pociot F, Wilson AG, Nerup J, Duff GW. (1993). No independent association between a TNFα promoter region polymorphism and insulin-dependent diabetes mellitus (IDDM). Eur J Immunol 23: 3050–3053.
Библиографическая ссылка 15 Pociot F et al. (1994). Analysis of a new TNFA promoter polymorphism on the IDDM-associated HLA-B18,-DR3 haplotype. Eur J Endocrinol 130: (suppl 1): 31.
Библиографическая ссылка 16 Roth M-P et al. (1994). Tumor necrosis factor polymorphisms in multiple sclerosis: no additional association independent of HLA. J Neuroimmunol 51: 93–99.
Библиографическая ссылка 17 Crouau-Roy B et al. (1993). TNF microsatellites in four European populations. Hum Immunol 38: 213–216.
Библиографическая ссылка 18 Poser CM et al. (1983). New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227–231.
Библиографическая ссылка 19 Jongeneel CV et al. (1991). Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes. Proc Natl Acad Sci (USA), 88: 9717–9721.
Библиографическая ссылка 20 Svejgaard A, Ryder LP. (1994). HLA and disease associations: Detecting the strongest association. Tissue Antigens 43: 18–27.
Библиографическая ссылка 21 Powell MB, Steinman L. (1992). The role of lymphotoxin and TNF in demyelinating diseases of the CNS. In: Beutler B (ed). Tumor necrosis factor. The molecule and their emerging role in medicine. Raven Press, New York: 355–369.
Библиографическая ссылка 22 Merrill JE, Ellison GW, Myers LW. (1984). Cytotoxic activity of peripheral blood and cerebrospinal fluid lymphocytes from patients with multiple sclerosis and other neurological diseases: analysis at the single cell level of the relationship of cytotoxic effects and interferon-producing cells. Clin Immunol Immuno-pathol 31: 390–402.
Библиографическая ссылка 23 Franciotta DM et al. (1989). Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis. Ann Neurol 26: 787–789.
Библиографическая ссылка 24 Gallo P, Piccinno MG, Krzalic L, Tavolato B. (1989). Tumor necrosis factor alpha (TNF-α) and neurological diseases. Failure in detecting TNFα in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumor. J Neuroimmunol 23: 41–44.
Библиографическая ссылка 25 Hauser SL et al. (1990). Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology 40: 1735–1739.
Библиографическая ссылка 26 Maimone D, Gregory S, Arnason BGW, Reder AT (1991). Cytokine levels in cerebrospinal fluid and serum of patients with multiple sclerosis. J Neuroimmunol 32: 67–74.
Библиографическая ссылка 27 Sharief MK, Hentges R. (1991). Association between tumor necrosis factorα and disease progression in patients with multiple sclerosis. N Engl J Med 325: 467–472.
Библиографическая ссылка 28 Peter JB, Boctor FN, Tourtellotte WW. (1991). Serum and CSF levels of IL-2, sIL-2, TNFα, and IL-1β in chronic progressive multiple sclerosis. Expected lack of clinical utility. Neurology, 41: 121–123.
Библиографическая ссылка 29 Sharief MK et al. (1994). Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNFα and blood-brain barrier damage. J Neuroimmunol 43: 15–22.
Библиографическая ссылка 30 Matsuda M, Tsukada N, Miyagi K, Yanagisawa N. (1994). Increased levels of soluble tumor necrosis factor receptor in patients with multiple sclerosis and HTLV-1αssociated myelopathy. J Neuroimmunol 52: 33–40.
Библиографическая ссылка 31 Chofflon M et al. (1992). Tumor necrosis factor α production as a possible predictor of relapse in patients with multiple sclerosis. Eur Cytokine Network 3: 523–531.
Библиографическая ссылка 32 Rudick RA, Ransohoff RM. (1992). Cytokine secretion by multiple sclerosis monocytes. Relationship to disease activity. Arch Neurol 49: 265–270.
Библиографическая ссылка 33 Mølvig J et al. (1988). Endotoxin-stimulated human monocyte secretion of inter-leukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable inter-individual differences. Scand J Immunol 27: 705–716.
Библиографическая ссылка 34 Robbins DS et al. (1987). Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol 139: 2593–2597.
Библиографическая ссылка 35 Selmaj K, Raine CS. (1988). Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23: 339–346.
Библиографическая ссылка 36 Ruddle NH et al. (1990). An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 172: 1193–1200.
Библиографическая ссылка 37 Udalova IA et al. (1993). Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 16: 180–186.
Библиографическая ссылка 38 Powell MB et al. (1990). Lymphotoxin and tumor necrosis factorα production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int Immunol 2: 539–544.

Скрыть метаданые